Stock Code


Stock Exchange


CSL is a biopharmaceutical conglomerate that develops, manufactures and markets products which act as treatment or prevention against human medical conditions. CSL operates globally through subsidiaries of CSL Behring, CSL Bioplasma and CSL Biotherapies. The company operates in 27 countries, with major manufacturing facilities in Australia, Germany, New Zealand, Switzerland and the US and has over 9000 employees.

CSL business operations have three separate divisions: pharmaceuticals and vaccines; plasma products; and research and development.

CSL Pharmaceuticals and Vaccines

CSL Profits Half Year US$626.9m

Australia's largest pharmaceutical company CSL (ASX:CSL) have reported its first half profits to the ASX (Australian Securities Exchange).

  • First half net profit came in at US$626.9 million, up 24.3 percent.
  • Earnings per share jumped 30 percent to US124.7 cents, from the CSL's ongoing share buyback

CSL Full Year Financial Report 2012

Blood products and vaccines producer CSL (ASX:CSL) have released their full year financial results for FY 2012 to the ASX stockmarket.

  • Specialty pharmaceutical company posted a net profit of $982.6 million, compared with $940.6 million the previous year.
  • Total revenue up to $4.4 billion from $4.2 billion the previous year.

The Sharemarket Boardroom Schedule For Next Wednesday

There are 12 companies that will hold their general meeting on October 19, 2011.


Share Market Diary for Next Monday

After meager numbers this week, dividends are back up with 15 stocks going on ex-dividend on September 19, 2011. Additionally two companies will hold their extraordinary general meeting.


Strong Aussie Dollar Can Cut CSL Profits

A strong Aussie dollar can cut into blood products and vaccines producer, CSL (ASX:CSL) by $100 million. At its Annual General Meeting (AGM) on Wednesday, the company reaffirmed its August forecast of fiscal 2011 net profit of between A$980 million and A$1.03 billion, at 2009/2010 exchange rates (at around US 90 cents). 90 percent of CSL's profits are generated offshore.

Worst Aussie Shares

Primary Health Care Limited, Onesteel Limited, Amp Limited, Billabong International Limited, Bhp Billiton Limited, Charter Hall Office Reit, Fairfax Media Limited, Downer Edi Limited, Axa Asia Pacific Holdings Limited and CSL Limited were among the worst Aussie Shares from the ASX 100 index. These stocks decreased their share price by the most percentage points on the Australian share market, the Australian Securities Exchange (ASX) from the previous week of trading.

CSL Profits Down

Pharmaceuticals company, CSL (ASX:CSL) have posted their annual net profit $1.053 billion, down 8.1 percent. Four months ago, the company had returned $1.8 billion back to investors and now, the company have announced a new $900 million share buyback due to a strong company Cashflow position and a great balance sheet.

CSL Dividends

CSL Dividends

9 August, 2010 - 20:51

Study the historical dividends for CSL LIMITED. Dividends are a portion of company profits paid out to shareholders. You are eligible to receive CSL dividends if you own the company's stock on the ex-dividend date. Investor's must have purchased the stock before the ex dividend date to be entitled to the dividend. The previous owner of the shares will receive the CSL dividend if you buy the stocks on or after the ex dividend date. The Pay Date or the Date Payable is the day when the dividend is paid to shareholders.

Australian Dollar Currency Influences Reporting Season

Currency fluctuations will influence the earnings reports and hence the upcoming company reporting season in Australia.

Syndicate content

Recommended Websites